Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,117,361
+$94,368 QoQ
Shares Held
16,212
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#1,752
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Certified Advisory Corp holds $12,736,081 across 8 Drug Manufacturers - General names. JNJ ranks #1 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
16,212 | $4,117,361 | |
| 2 | LLY |
ELI LILLY & Co
|
3,249 | $3,896,948 | |
| 3 | ABBV |
AbbVie Inc.
|
7,683 | $1,933,350 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,732 | $850,520 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,383 | $820,215 | |
| 6 | AMGN |
Amgen Inc
|
1,762 | $638,055 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,692 | $270,353 | |
| 8 | PFE |
Pfizer Inc
|
8,691 | $209,279 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,117,361 | 16,212 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,022,993 | 16,458 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $3,526,841 | 17,042 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $3,278,411 | 17,681 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,700,925 | 17,682 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,160,744 | 19,059 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,717,988 | 18,794 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,124,516 | 19,280 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,836,234 | 19,405 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,124,568 | 19,752 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,015,834 | 19,241 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,901,310 | 18,628 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,180,632 | 19,216 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,184,165 | 20,543 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $3,673,259 | 20,794 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $3,356,231 | 20,545 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,825,517 | 21,551 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,627,720 | 20,469 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,614,366 | 21,128 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,432,036 | 21,251 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,537,132 | 21,471 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,575,104 | 21,753 | Shares | Defined | 2021-05-10 | |
| 2020-06-30 | $2,896,414 | 20,596 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $2,470,488 | 18,840 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||